ASNC-ACC-Letter-to-Congress_Price-Transparency-Legislation_02-01-2024
In February 2024, ASNC and the American College of Cardiology shared with Senate leaders concerns about the implications of Section 4 of S.3458, the Health Care PRICE Transparency Act 2.0, which posed an unnecessary administrative burden on already strained physician practices and would not have resulted in a patient-centric solution to price transparency. Section 4 would likely have impacted the vast majority of physicians, ranging from small family practices to specialists—all of whom provide imaging services in the office setting.
Resource Type
Health Policy Memos
Related Resources
PET Case: Identifying Epicardial Coronary Artery Disease in a Patient With Paroxysmal Atrial Fibrillation Using [15O]H2O PET
Case summary: This case highlights the ability of [15O]H2O PET to accurately…
ASNC, ACC Comment to Commerce Department on Radiopharmaceutical Imports
ASNC-ACC-Radiopharms-Tariff-Letter_05-07-2025 ASNC and the American College of Cardiology submitted comments on a…
PET Case: Very High-Risk PET MPI
Case summary: This case illustrates the value of cardiac PET MPI for…